- completedNot Applicable
Can a nuclear medicine scan (MIBI-kidney) tell us if a mass in the kidney is cancer?
Around 3 in 10 kidney lumps are harmless and do not need surgery. Doctors currently use biopsies or operations to check them. This study tests a gentle, painless scan called a MIBI scan to see if it can spot whether a kidney lump is cancer without needing invasive surgery.
United Kingdom · England - recruitingPhase I and Phase II (Integrated)- Other
CA209-8KX Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy
This study is looking at a new way to give nivolumab, a cancer medicine, through an injection under the skin. It's for people with various advanced cancers like lung, kidney, and liver cancer, to see how the body handles the medicine and if it's safe.
Spain · Netherlands · Italy - recruiting
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
This study, called i-RECORD, is looking at the best ways to treat kidney cancer around the world. It compares different treatments like surgery, burning off tumours, or just watching them closely. The aim is to understand which treatments work best for different people and improve future care.
United States · Austria · Belgium - recruitingPHASE4
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
This study looks at how well a treatment combining two drugs, nivolumab and cabozantinib, works for older patients (70 and over) with advanced kidney cancer. It aims to see how patients respond to this treatment in real-life use.
France - authorisedTherapeutic exploratory (Phase II)
A Phase 2 BIOmarker driven trial with Nivolumab and Ipilimumab or VEGFR tKi in naïve metastatic Kidney cancer
This study is looking at new drug combinations (Nivolumab and Ipilimumab, or a VEGFR tKi) for kidney cancer that has spread. It aims to see how many people respond to the treatments and how long those responses last, hoping to find better ways to fight the cancer.
France - recruitingNA
Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques
This study uses new MRI scans to tell the difference between harmless and cancerous kidney growths. It aims to reduce unnecessary operations or tests for people with harmless growths by developing better ways to see inside the body.
United Kingdom - recruiting
Ex VIvo DEtermiNed Cancer Therapy
This study, called EVIDENT, wants to see if we can test a tiny piece of your tumour in the lab to predict how well cancer treatments will work for you. It's for people with various solid cancers, like bladder or kidney cancer, who are having surgery or a biopsy.
United Kingdom